Fundraising FoxVillya
Melbourne, US · Founded 2020 · Delaware LLC
Find your way into Villya
Sign up to see every warm intro you have to Villya
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Villya team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Villya Pharmaceuticals develops water-soluble reformulations of existing drugs using a patented carbohydrate-loading technology, including liquid praziquantel, a topical gel for Female Genital Schistosomiasis, second-generation erectile dysfunction medications, and oral peptide therapeutics such as semaglutide and insulin. The company focuses on improving solubility, gastric stability, and delivery of pharmaceuticals to enable oral administration of otherwise injectable medicines.
Founders & leadership
Villya was founded in 2020 by William Miller.
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2023
▶$250KraisedDec 2023 · 1 investors · PharmaceuticalsRule 506(b)
- Ron RayExecutive Officer, Director
- Diana MillerExecutive Officer
- William MillerExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $250K
- Minimum investment
- $10K
- First sale
- Dec 2023
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Villya do?
- Villya Pharmaceuticals develops water-soluble reformulations of existing drugs using a patented carbohydrate-loading technology, including liquid praziquantel, a topical gel for Female Genital Schistosomiasis, second-generation erectile dysfunction medications, and oral peptide therapeutics such as semaglutide and insulin. The company focuses on improving solubility, gastric stability, and delivery of pharmaceuticals to enable oral administration of otherwise injectable medicines.
- Who founded Villya?
- Villya was founded by William Miller in 2020.
- How much funding has Villya raised?
- Villya has disclosed $250K raised across 1 round.
- Where is Villya headquartered?
- Villya is headquartered in Melbourne, US.